Ann Arbor, MI, United States of America

Changyong Xue

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Michigan. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Changyong Xue. Retrieved from https://idiyas.com/inventor/changyong-xue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Changyong Xue: Innovator in Peptide Compositions

Introduction

Changyong Xue is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of peptide compositions, particularly in the treatment of various metabolic conditions. With a total of 2 patents, his work is paving the way for innovative therapeutic approaches.

Latest Patents

Changyong Xue's latest patents focus on peptide compositions and methods for treating patients. The first patent is directed to peptide compositions and methods of using these compositions to treat prediabetes, diabetes, obesity, high blood pressure, and metabolic syndrome. This innovative approach aims to provide effective solutions for managing these prevalent health issues.

Career Highlights

Changyong Xue is affiliated with the University of Michigan, where he continues to advance research in peptide therapies. His work is characterized by a commitment to improving patient outcomes through scientific innovation.

Collaborations

Some of his notable coworkers include Yuqing E Chen and Jifeng Zhang. Their collaborative efforts contribute to the ongoing research and development in the field of peptide compositions.

Conclusion

Changyong Xue's contributions to peptide compositions represent a significant advancement in medical science. His innovative approaches are set to impact the treatment of metabolic disorders positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…